Miranda Schmalfuhs

Articles by Miranda Schmalfuhs

Pharma Pulse 7/24/24: Addressing OUD Treatment Gaps, Body Dysmorphic Disorder Most Common in Adolescent Girls & more

ByMiranda Schmalfuhs

July 24th 2024

The latest news for pharma industry insiders.

Pharma Pulse 7/23/24: The Data That Powers AI is Disappearing Fast, Stay Aware of Common High-Alert Medications & more

ByMiranda Schmalfuhs

July 23rd 2024

The latest news for pharma industry insiders.

Pharma Pulse 7/22/24: Global Diabetes & Obesity Therapeutics Study, Is There a Correlation Between Medical Debt and Delayed Mental Health Care? & more

ByMiranda Schmalfuhs

July 22nd 2024

The latest news for pharma industry insiders.

Pharma Pulse 7/19/24: GE HealthCare Agrees to Acquire Clinical AI Business, Essential Approaches for Effective Brand Narratives & more

ByMiranda Schmalfuhs

July 19th 2024

The latest news for pharma industry insiders.

Pharma Pulse 7/18/24: Stigma, Price Point Major Obstacles for Widespread OTC Naloxone Use, RedBox Rx Launches Online Talk Therapy Services & more

ByMiranda Schmalfuhs

July 18th 2024

The latest news for pharma industry insiders.

Pharma Pulse 7/17/24: OpenAI Scale Ranks Progress Toward ‘Human-Level’ Problem Solving, Increased Use of GLP-1 Drugs Adds to Navitus’ Drug Spend & more

ByMiranda Schmalfuhs

July 17th 2024

The latest news for pharma industry insiders.

Pharma Pulse 7/16/24: Universities Don’t Want AI Research to Leave Them Behind, The AI Revolution Comes to Pharmacy & more

ByMiranda Schmalfuhs

July 16th 2024

The latest news for pharma industry insiders.

Pharma Pulse 7/15/24: What to Know About Medication and Summer Travel, The Future of Periodontal Treatment & more

ByMiranda Schmalfuhs

July 15th 2024

The latest news for pharma industry insiders.

Pharma Pulse 7/12/24: The Weight-Loss Gold Rush, GSK Begins Shipping 24-25 Influenza Vaccines & more

ByMiranda Schmalfuhs

July 12th 2024

The latest news for pharma industry insiders.

Pharma Pulse 7/11/24: Thermo Fisher Scientific Completes Acquisition of Olink, 7 Takeaways From the FTC Interim Report on PBMs & more

ByMiranda Schmalfuhs

July 11th 2024

The latest news for pharma industry insiders.

Pharma Pulse 7/10/24: Study Connects Multivitamin Use With Mortality Risk, Can Data and AI Deliver Whole-Person Health? & more

ByMiranda Schmalfuhs

July 10th 2024

The latest news for pharma industry insiders.

Pharma Pulse 7/9/24: Technology Designed to Support Infertility, Patients with Type 1 Diabetes Have Higher Risk of Epilepsy & more

ByMiranda Schmalfuhs

July 9th 2024

The latest news for pharma industry insiders.

Pharma Pulse 7/8/24: Moderna Awarded $176 Million, Palliative Care Strategies Can Improve the Management of Cardiovascular Disease & more

ByMiranda Schmalfuhs

July 8th 2024

The latest news for pharma industry insiders.

Pharma Pulse 7/5/24: Annual Life Sciences Good Manufacturing Practices Master Class 2024, FDA Grants Marketing Authorization for Rapid Hep C Test

ByMiranda Schmalfuhs

July 5th 2024

The latest news for pharma industry insiders.

Pharma Pulse 7/4/24: Semaglutide Associated with Optic Neuropathy That Can Lead to Blindness, FDA Approves Lilly’s Kisunla & more

ByMiranda Schmalfuhs

July 4th 2024

The latest news for pharma industry insiders.

Pharma Pulse 7/3/24: Reactions to New FDA Diversity Action Plan Guidance, Walgreens Strengthens Support for Children and Adults Living with Diabetes & more

ByMiranda Schmalfuhs

July 3rd 2024

Pharma Pulse 7/2/24: AI’s Promise in Delivering on Patient-Centricity, What’s Complicating Good Data Practices and Data Integrity? & more

ByMiranda Schmalfuhs

July 2nd 2024

The latest news for pharma industry insiders.

Pharma Pulse 7/1/24: How Can Incoming, Existing Executives Build a Sustainable Role?

ByMiranda Schmalfuhs

July 1st 2024

The latest news for pharma industry insiders.

Pharma Pulse 6/28/24: Pharmacy Closure Contributors, The Long-Term Consequences & more

ByMiranda Schmalfuhs

June 28th 2024

The latest news for pharma industry insiders.

Pharma Pulse 6/27/24: Pharmacy Deserts & Underserved/Rural Communities, GoodRx Launches New “Prescription Cost Tracker” & more

ByMiranda Schmalfuhs

June 27th 2024

The latest news for pharma industry insiders.

Pharma Pulse 6/26/24: How to Thrive in a Cookie-Less Era, Why Consumers are Switching Providers and Payers & more

ByMiranda Schmalfuhs

June 26th 2024

The latest news for pharma industry insiders.

Pharma pulse 6/25/24: Novo Nordisk Invests $4.1 billion to Expand US Manufacturing, Improving the Efficacy of Genetic Medicines & more

ByMiranda Schmalfuhs

June 25th 2024

The latest news for pharma industry insiders.

Pharma Pulse 6/24/24: Accelerating Clinical Trial Activation, Humans Need to Be Factored Into AI Trust and Acceptance & more

ByMiranda Schmalfuhs

June 24th 2024

The latest news for pharma industry insiders.

Pharma Pulse 6/21/24: Global Mortality and Disability from Type 1 Diabetes Have Decreased, What Leaders of Effective Teams Know & more

ByMiranda Schmalfuhs

June 21st 2024

Pharma Pulse 6/20/24: Talkspace and FitOn Team Up, The Potential of CAR-T Therapies & more

ByMiranda Schmalfuhs

June 20th 2024

The latest news for pharma industry insiders.

Pharma Pulse 6/19/24: DIA 2024 Coverage, How Orange Peels Connect to Heart Health & more

ByMiranda Schmalfuhs

June 19th 2024

The latest news for pharma industry insiders.

Pharma Pulse 6/18/24: ADHD Opportunity Assessment and Forecasts, Ensuring Ethical GLP-1 Practices & more

ByMiranda Schmalfuhs

June 18th 2024

The latest news for pharma industry insiders.

Pharma Pulse 6/17/24: Pet Care Industry Eyes GLP-1s, Improving Quality of Care for Cancer Patients & more

ByMiranda Schmalfuhs

June 17th 2024

Pharma Pulse 6/14/24: Weight Loss Drug Shortages Prompt Shortage Tracking Platforms, Build Trust with Patients to Overcome Misinformation & more

ByMiranda Schmalfuhs

June 14th 2024

The latest news for pharma industry insiders.

Pharma Pulse 6/13/24: IQVIA Launches “One Home” Platform, Coverage for GLP-1 Drugs for Obesity is in Flux & more

ByMiranda Schmalfuhs

June 13th 2024

The latest news for pharma industry insiders.

Miranda Schmalfuhs

Articles by Miranda Schmalfuhs

Pharma Pulse 7/24/24: Addressing OUD Treatment Gaps, Body Dysmorphic Disorder Most Common in Adolescent Girls & more

Pharma Pulse 7/23/24: The Data That Powers AI is Disappearing Fast, Stay Aware of Common High-Alert Medications & more

Pharma Pulse 7/22/24: Global Diabetes & Obesity Therapeutics Study, Is There a Correlation Between Medical Debt and Delayed Mental Health Care? & more

Pharma Pulse 7/19/24: GE HealthCare Agrees to Acquire Clinical AI Business, Essential Approaches for Effective Brand Narratives & more

Pharma Pulse 7/18/24: Stigma, Price Point Major Obstacles for Widespread OTC Naloxone Use, RedBox Rx Launches Online Talk Therapy Services & more

Pharma Pulse 7/17/24: OpenAI Scale Ranks Progress Toward ‘Human-Level’ Problem Solving, Increased Use of GLP-1 Drugs Adds to Navitus’ Drug Spend & more

Pharma Pulse 7/16/24: Universities Don’t Want AI Research to Leave Them Behind, The AI Revolution Comes to Pharmacy & more

Pharma Pulse 7/15/24: What to Know About Medication and Summer Travel, The Future of Periodontal Treatment & more

Pharma Pulse 7/12/24: The Weight-Loss Gold Rush, GSK Begins Shipping 24-25 Influenza Vaccines & more

Pharma Pulse 7/11/24: Thermo Fisher Scientific Completes Acquisition of Olink, 7 Takeaways From the FTC Interim Report on PBMs & more

Pharma Pulse 7/10/24: Study Connects Multivitamin Use With Mortality Risk, Can Data and AI Deliver Whole-Person Health? & more

Pharma Pulse 7/9/24: Technology Designed to Support Infertility, Patients with Type 1 Diabetes Have Higher Risk of Epilepsy & more

Pharma Pulse 7/8/24: Moderna Awarded $176 Million, Palliative Care Strategies Can Improve the Management of Cardiovascular Disease & more

Pharma Pulse 7/5/24: Annual Life Sciences Good Manufacturing Practices Master Class 2024, FDA Grants Marketing Authorization for Rapid Hep C Test

Pharma Pulse 7/4/24: Semaglutide Associated with Optic Neuropathy That Can Lead to Blindness, FDA Approves Lilly’s Kisunla & more

Pharma Pulse 7/3/24: Reactions to New FDA Diversity Action Plan Guidance, Walgreens Strengthens Support for Children and Adults Living with Diabetes & more

Pharma Pulse 7/2/24: AI’s Promise in Delivering on Patient-Centricity, What’s Complicating Good Data Practices and Data Integrity? & more

Pharma Pulse 7/1/24: How Can Incoming, Existing Executives Build a Sustainable Role?

Pharma Pulse 6/28/24: Pharmacy Closure Contributors, The Long-Term Consequences & more

Pharma Pulse 6/27/24: Pharmacy Deserts & Underserved/Rural Communities, GoodRx Launches New “Prescription Cost Tracker” & more

Pharma Pulse 6/26/24: How to Thrive in a Cookie-Less Era, Why Consumers are Switching Providers and Payers & more

Pharma pulse 6/25/24: Novo Nordisk Invests $4.1 billion to Expand US Manufacturing, Improving the Efficacy of Genetic Medicines & more

Pharma Pulse 6/24/24: Accelerating Clinical Trial Activation, Humans Need to Be Factored Into AI Trust and Acceptance & more

Pharma Pulse 6/21/24: Global Mortality and Disability from Type 1 Diabetes Have Decreased, What Leaders of Effective Teams Know & more

Pharma Pulse 6/20/24: Talkspace and FitOn Team Up, The Potential of CAR-T Therapies & more

Pharma Pulse 6/19/24: DIA 2024 Coverage, How Orange Peels Connect to Heart Health & more

Pharma Pulse 6/18/24: ADHD Opportunity Assessment and Forecasts, Ensuring Ethical GLP-1 Practices & more

Pharma Pulse 6/17/24: Pet Care Industry Eyes GLP-1s, Improving Quality of Care for Cancer Patients & more

Pharma Pulse 6/14/24: Weight Loss Drug Shortages Prompt Shortage Tracking Platforms, Build Trust with Patients to Overcome Misinformation & more

Pharma Pulse 6/13/24: IQVIA Launches “One Home” Platform, Coverage for GLP-1 Drugs for Obesity is in Flux & more

Trending on Pharmaceutical Commerce

Pharma Pulse: Amazon Enters Weight-Loss Drug Market, Merck Expands US Manufacturing, and FDA Approves Tezspire for Chronic Sinusitis

Frontier Scientific Solutions, ATSG Partner to Launch Air Network for Temperature-Controlled Pharmaceuticals

The Hidden Costs of Specialty Drug Access and Patient Loneliness

Preventing Sample Loss in a Systemic Power Failure

Your Guide to Outsourcing Critical Sample Management